menu search

Orthopediatrics corp. to host educational and networking events at 18th annual international pediatric orthopaedic symposium (ipos)

Continues IPOS Corporate Partnership as Double Diamond Sponsor WARSAW, Ind., Dec. 05, 2022 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatr...

December 5, 2022, 9:05 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 10:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 10:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m

AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

December 2, 2022, 5:02 pm

Ecb speakers coming up on thursday, 1 december 2022 - lagarde, enria, elderson

European Central Bank speakers coming up, gonna have to wait for Lagarde! It looks like she is the most likely to make remarks pertinent to the mar...

December 1, 2022, 3:14 am

Athira pharma to present preclinical data highlighting therapeutic potential of ath-1105 in als at the 33rd international symposium on als/mnd

HGF/MET small molecule positive modulator provides neuroprotection and improves motor and nerve function in a TDP-43 mouse model of ALS HGF/MET small ...

November 28, 2022, 7:00 am

Dollar recovering slightly in consolidative markets, breakout awaited

The currency markets are generally quiet, without committed directions. Dollar is recovering broadly, ahead of near term support against European majo...

November 8, 2022, 6:01 am

Robinhood markets, inc. to present at the wolfe research wealth symposium on november 8, 2022

MENLO PARK, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Today, Robinhood Markets, Inc. (NASDAQ: HOOD) announced that it will be participating in the upc...

November 4, 2022, 4:10 pm

Moleculin selected to present at the 2nd annual marie sklodowska-curie symposium on cancer research and care

HOUSTON , Sept. 8, 2022 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical comp...

September 8, 2022, 8:45 am

Abbvie to present data from its robust migraine portfolio at the migraine trust international symposium 2022

--Results from the PROGRESS Phase 3 trial on atogepant for the preventive treatment of chronic migraine will be showcased as an oral presentation --Br...

September 8, 2022, 4:00 am

Nuvalent to present preliminary phase 1 data from arros-1 clinical trial of nvl-520 at 34th eortc-nci-aacr symposium and announces pipeline updates

Preliminary Dose Escalation Data on ROS1-selective Inhibitor NVL-520 to be Presented in the "New Drugs on the Horizon" Oral Plenary Session New Precli...

September 7, 2022, 6:30 am


Search within

Pages Search Results: